Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet FID-MIBI 1mg kit for radiopharmaceutical preparations
- Product code:
- W65017002
- Quantity:
- 6
- Indicated for:
- diagnostic imaging
- Route of administration:
- injectable
- Substance:
- radiopharmaceuticals (contrast agent)
- ATC
- V09GA01 — Various | Cardiovascular system | Technetium (99mtc) compounds
Precautions:
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Additional monitoring
This medicine is subject to additional monitoring.
Radiopharmaceuticals are substances used in nuclear medicine for the diagnosis and treatment of various conditions. They contain radioactive isotopes that emit detectable radiation for imaging, such as positron emission tomography (PET) or scintigraphy.
Radiopharmaceuticals are administered intravenously, orally, or by inhalation, depending on the type of investigation or treatment. It is important for these substances to be handled and administered by qualified personnel to minimize radiation exposure.
Patients should be informed about potential risks, such as radiation exposure or allergic reactions. It is important to follow all instructions provided before and after the procedure.
Side effects are rare but may include allergic reactions or discomfort at the injection site. In very rare cases, complications related to radiation exposure may occur. Patients should be informed of these risks before use.
Radiopharmaceuticals are administered intravenously, orally, or by inhalation, depending on the type of investigation or treatment. It is important for these substances to be handled and administered by qualified personnel to minimize radiation exposure.
Patients should be informed about potential risks, such as radiation exposure or allergic reactions. It is important to follow all instructions provided before and after the procedure.
Side effects are rare but may include allergic reactions or discomfort at the injection site. In very rare cases, complications related to radiation exposure may occur. Patients should be informed of these risks before use.
General data about FID-MIBI 1mg
- Substance:
- radiopharmaceuticals
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W65017002
- Concentration:
- 1mg
- Pharmaceutical form:
- kit for radiopharmaceutical preparations
- Quantity:
- 6
- Product type:
- Generic medicine
- Price:
- 7962.31 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for radiopharmaceuticals
- 1mg
- 20mcg